Ophthalmology Doctors in Paducah, KY Accepting Medicare

7 Ophthalmology doctors found. Showing 1 - 7

Ted Borodofsky, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 1903 Broadway St, Paducah, KY 42001 Phone: 270-442-1671    Fax: 270-442-7307

Dr. Landen A Meeks, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 4630 Village Square Dr, Paducah, KY 42001 Phone: 270-442-1671    Fax: 270-442-7307

Jeffery M Taylor, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 4630 Village Square Dr, Paducah, KY 42001 Phone: 270-442-1671    Fax: 270-442-7307

Barbara Bowers, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1130 Lone Oak Road, Paducah, KY 42003 Phone: 270-415-0245

Carl W Marquess Jr., MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 1750 Broadway St, Paducah, KY 42001 Phone: 270-442-2744    Fax: 270-443-5956

Jeff Johnson, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 1903 Broadway St, Paducah, KY 42001 Phone: 270-442-1671    Fax: 270-442-7307

Mark E Gillespie, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 4630 Village Square Dr, Paducah, KY 42001 Phone: 270-442-1671    Fax: 270-442-7307

News Archive

Western University imaging scientists develop better way to track progression of MS

Imaging scientists at Western University's Robarts Research Institute (London, Canada) have developed a better way to track the progression of Multiple Sclerosis (MS) from its earliest stages.

New study suggests that homes pollute up to 50 percent more than the past estimates

They say there's no place like home. But scientists are reporting some unsettling news about homes in the residential areas of California. The typical house there - and probably elsewhere in the country - is an alarming and probably underestimated source of water pollution, according to a new study reported today at the 238th National Meeting of the American Chemical Society.

Final patient completion of phase II study of TR040303 in patients treated for acute myocardial infarction announced by Trophos

Trophos SA, a clinical stage pharmaceutical company developing innovative therapeutics from discovery to clinical validation for indications with under-served needs in neurology and cardiology, announces today the final patient completion of a phase II study of TR040303 in patients treated for acute myocardial infarction (MI). Outcome data of this study is expected to be available towards the end of 2013.

EntreMed adds DF/HCC hospitals to Phase 2 study of ENMD-2076 for platinum resistant ovarian cancer

EntreMed, Inc., today announced the addition of Dana Farber/Harvard Cancer Center (DF/HCC) to the Phase 2 multi-center study entitled "A Phase 2 Study of Oral ENMD-2076 Administered to Patients with Platinum Resistant Ovarian Cancer." Ursula Matulonis, M.D., Associate Professor of Medicine, Dana-Farber Cancer Institute and Harvard Medical School, will serve as principal investigator.

Political cartoon: 'The Bomb'

Kaiser Health News provides a fresh perspective on health policy developments with "The Bomb" by John Hambrock.

Read more Medical News

› Verified 6 days ago